Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.850
0.00 (0.00%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Revenue

In the year 2025, Whitehawk Therapeutics had annual revenue of $7.15M, down -72.50%.

Revenue (ttm)
$7.15M
Revenue Growth
-72.50%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
207.07M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.15M-18.84M-72.50%
Dec 31, 202425.98M1.63M6.69%
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M--
Dec 31, 2019---
Dec 31, 201820.16M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Cellectis75.11M
Compugen72.66M
Coherus Oncology46.88M
Atrium Therapeutics36.68M
Keros Therapeutics33.18M
AC Immune4.62M
Revenue Rankings

WHWK News

More News